The US FDA withdraws approval of anti-malaria drug for covid-19

 The US Food and Drug Administration has withdrawn the emergency use of the anti-malaria drug hydroxychloroquine as a treatment for coronavirus. The FDA said that new evidence from clinical trials meant that it was no longer reasonable to believe that the drug would produce an antiviral effect. President Donald Trump defended promoting the use of hydroxychloroquine after dosing himself with the drug when White House staffers were infected.

Coronavirus cases worldwide have passed 8 million. More than 3.8 million have recovered, while at least 435,662 have died, according to data compiled by Johns Hopkins University. The US, Brazil and the UK have reported the most deaths.



Print Friendly, PDF & Email